Portfolio company
Brickell Biotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops prescription therapeutics for patients with skin diseases, such as hyperhidrosis, atopic dermatitis, and acne.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brickell Bio
This pharmaceutical company develops prescription therapeutics for patients with autoimmune, inflammatory and debilitating skin diseases.
Dermira
This biopharmaceutical company develops and commercialises medical dermatology treatments for patients with chronic skin conditions such as excessive sweating and atopic dermatitis.
Arcutis Biotherapeutics
This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.
Journey Medical
This pharmaceutical company develops and sells prescription medicines to treat dermatological conditions, such as rosacea and acne, for patients and healthcare professionals.
DermBiont
This clinical-stage biotechnology company develops targeted topical therapeutics to treat skin diseases, such as hyperpigmentation and seborrheic keratoses, for patients with dermatological conditions.
Arcutis
This company develops and commercialises topical treatments for patients living with chronic immune-mediated dermatological diseases including psoriasis, seborrhoeic dermatitis and atopic dermatitis.
Infinimmune
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
Anacor
Anacor Pharmaceuticals develops small-molecule therapeutics for fungal, bacterial and inflammatory diseases for patients with conditions such as onychomycosis and atopic dermatitis.
